Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/10/2016 → 31/12/2020 |
Collaborative partners
- King's College London (lead)
- MRC Medical Research Council
Funding
- Celgene Corporation: £625.00
- Celgene Corporation: £90,000.00
Understanding how immunomodulatory drugs affect tumour microenvironment (TME)-driven immune suppression
- Ramsay, Alan (Primary Investigator)
Project: Research